Hematology Market

The global Hematology diagnostics and drugs market is likely to expand from nearly $86.5 billion in 2015 to $124.3 billion in 2020 at a five-year compound annual growth rate (CAGR) of 7.5%. A Blood disorder, the chief segment is anticipated to reach nearly $57.3 billion and $80 billion in 2015 and 2020, respectively, representing five-year CAGR of 6.9%. Hematological oncology is the fastest-growing segment, should raise almost $24 billion in 2015 to $38.2 billion in 2020 at a five-year CAGR of 9.7%. Reagents and diagnostics as a segment should reach $6.1 billion in 2020 at a five-year CAGR of 3.2%.

The Americas controlled the largest share of 41.75% of the worldwide Hematology market at a predicted $1,810.4 million in 2013, anticipated to reach $2,479.05 million by 2018, at a CAGR of 6% from 2013 to 2018. Europe holds the second largest Hematology market share. Germany precise the largest share almost 20% of the European market at an anticipated $272.8 million in 2013, and is estimated to grasp $349.7 million by 2018, at a CAGR of 5.4% from 2013 to 2018. The Asia and Middle East Hematology market is growing in double digits and will remain to grow in the upcoming years. China controlled the major share of almost 53% of the Asian Hematology market at a predictable $216.0 million in 2013, estimated and is to grasp $429.1 million by 2018, at a CAGR of 15.4% from 2013 to 2018.

    Related Conference of Hematology Market

    November 08-09, 2017

    11th International Conference on Hematology & Hematological Oncology

    Las Vegas, Nevada, USA
    March 15-16, 2018

    12th World
    Hematologists Congress

    London, UK
    September 20-21, 2018

    Hematologists Global Summit 2018

    Bali, Indonesia

    Hematology Market Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in